Will Americans ever be able to afford weight loss drugs?
Next generation weight loss drugs are prohibitively expensive for many in the US who would benefit from taking them—and may remain so, thanks to the phenomenon of patent thickets. Paige Huffman report...
My latest with the BMJ. GLP-1s have proven to be highly effective — and expensive. Pharma companies have thrown consumers a rare direct-to-consumer bone, but is it enough? Come along with me as I try to figure out why, and how long they’ll stay this costly.
bmj.com/cgi/content/...
25.11.2025 16:50
👍 2
🔁 0
💬 0
📌 0
I want to cross stitch while watching re-runs of vanderpump rules I don’t want to monitor the dismantling of my country’s public health infrastructure.
03.02.2025 19:23
👍 3
🔁 0
💬 0
📌 0
Trump freeze on NIH grant reviews alarms scientists, with long-term impact uncertain
Scientists nationwide said the cancellation of NIH grant reviews has thrown early-career scientists into limbo
This is a very good story on the uncertainty created by the disruption to NIH activity — and how the stakes are highest for the most junior scholars.
There's also a submission form at the bottom to share your experiences if the pause has impacted you. www.statnews.com/2025/01/24/t...
24.01.2025 16:54
👍 37
🔁 25
💬 1
📌 1
Hi everyone! I'm a DC-based healthcare policy analyst and occasional journalist writing about the interaction between health and business in the US. I'm interested in the insurance industry, private equity in healthcare, and the impact of high costs on the health of Americans. Great to be here!
16.01.2025 19:35
👍 6
🔁 1
💬 1
📌 1